Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 245 of 5804
-
New drug aims to tame overactive thyroid in Graves' disease
Disease control Recruiting nowThis study is being conducted to look at the effect YB-101 has on thyroid function. This study will also evaluate how safe and well tolerated YB-101 is and how it is distributed through the body. The study consists of a part 1, blinded treatment period, and a part 2 double-blind…
Phase: PHASE2 • Sponsor: Yarrow Bioscience, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Simple urine test could spot pancreatic cancer early
Diagnosis Recruiting nowThe main purpose of the study is to assess the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma (PDAC) the most common type of pancreatic cancer that accounts for approximately 90% of all pancreatic cancer cases. The study aims to characterize the per…
Sponsor: Urteste S.A • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New shot could help thyroid patients who Don't respond to usual pills
Disease control Recruiting nowThe main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how i…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough childhood blood cancers
Disease control Not yet recruitingThis is a phase I, open-label, dose-escalation clinical trial. The primary objectives are to assess the safety of PA3-17 injection in pediatric and adolescent participants with relapsed/refractory T-lymphoblastic leukemia/lymphoma, and determine the recommended phase II dose of P…
Phase: PHASE1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to shield autoimmune patients from Life-Threatening infections
Disease control Recruiting nowA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment with B-cell Depletion Therap…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Sniffing out cancer: new breath test could spot colon cancer before it spreads
Diagnosis Not yet recruitingThe goal of this observational study is to see whether a new, noninvasive test that analyzes smells (odor) from breath and intestinal gas can help detect colorectal cancer and precancerous growths at an early stage. The main questions it aims to answer are: Can the new odor-bas…
Sponsor: Beijing University of Chinese Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New pill combo aims to fight stomach cancer when first treatment fails
Disease control Recruiting nowThe goal of this study is to evaluate the efficacy and safety of oral paclitaxel solution plus fruquintinib as second-line therapy in adult subjects with advanced or metastatic gastric (G) or gastroesophageal junction (GEJ) cancer.
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo aims to stop HPV head and neck cancer recurrence
Disease control Recruiting nowThe goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Human Papillomavirus Positive HPV-positive head and neck cancer who have detectable minimal-residual disease after definitiv…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug combo aims to keep childhood leukemia at bay after transplant
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of ASTX727 and filgrastim for the treatment of children with high risk acute myeloid leukemia that has come back after a period of improvement (recurrent) or that does not respond to treatment (refractory) who have …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New combo pill aims to extend life in tough bile duct cancer
Disease control Recruiting nowThe object of this trial is to evaluate the efficacy of D07001-softgel capsules + capecitabine compared with placebo + capecitabine by overall survival (OS). Eligible patients with advanced biliary tract cancer (BTC) will be randomized (1:1:1) to receive either 60 mg D07001-soft…
Phase: PHASE3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug cocktail aims to fight tough esophageal cancer
Disease control Recruiting nowThis trial is a registrational Phase II/III, randomized, controlled, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 in combination with tislelizumab ± 5-FU in patients with unresectable, locally advanced recurrent or metastatic esophageal squamous c…
Phase: PHASE2, PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New program aims to stop depression before it starts in stressed teens
Prevention Not yet recruitingAmerican youth and young adults face persistent and chronic stressors, which have contributed to a mental health crisis in the United States. Four in 10 American high school students experience chronic feelings of sadness and hopelessness, 2 in 10 report suicidal ideation, and 1 …
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Radiosurgery zaps cancer pain when opioids fail
Symptom relief Recruiting nowThe investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as neuromodulate the centromedian and parafascicular complexes within the thalami - the so-called triple target. This invol…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New combo therapy aims to personalize lung cancer treatment
Disease control Recruiting nowBackground: While third-generation EGFR tyrosine kinase inhibitors (TKI) like aumolertinib have significantly improved outcomes for patients with advanced lung adenocarcinoma, those harboring the L858R mutation still experience inferior prognosis compared to those with exon 19 de…
Phase: PHASE2 • Sponsor: Taipei Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe purpose of this study is to test the safety of MSK-TCR5 in participants with advance solid tumor cancer that has a KRAS, HRAS, or NRAS G12D mutation.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Glowing dye may make pancreatic surgery safer
Disease control Recruiting nowPostoperative pancreatic fistula is the most important complication after laparoscopic distal pancreatectomy for tumors of the body and tail of the pancreas. It can cause infection, bleeding, longer hospital stay, and even death. New imaging technology using indocyanine green (IC…
Phase: NA • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Tailor-Made vaccine aims to train immune system against cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of ABO2109 in combination with toripalimab, and to evaluate the immunogenicity, pharmacokinetics, pharmacodynamics, as well as biomarker characteristics of the investigational cancer vaccine. In addition, the an…
Phase: EARLY_PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to tailor myeloma treatment to each patient
Disease control Not yet recruitingThe purpose of the study is to determine the best treatment approach based on the risk profile of the cancer cells and on how the disease responds to treatment. This is a randomized research study evaluating treatment for transplant-eligible participants with newly diagnosed mult…
Phase: PHASE3 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for rare genetic disorder in kids
Disease control Recruiting nowThis Phase 3, open-label extension, multicenter study will evaluate long-term safety, tolerability and efficacy of NNZ-2591 in pediatric participants with Phelan- McDermid Syndrome.
Phase: PHASE3 • Sponsor: Neuren Pharmaceuticals Limited • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Pill form chemo shows promise for older lung cancer patients in new trial
Disease control Not yet recruitingThis study is a multicenter, single-arm Phase II clinical trial, aiming to explore the safety and preliminary efficacy of oral paclitaxel solution combined with immune checkpoint inhibitors as a neoadjuvant regimen in elderly patients aged 70-85 years with non-small cell lung can…
Phase: NA • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC